Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125487601 | 12548760 | 1 | I | 20160630 | 20160712 | 20160712 | EXP | GB-B. BRAUN MEDICAL INC.-1054918 | B BRAUN | 67.00 | YR | M | Y | 0.00000 | 20160712 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125487601 | 12548760 | 1 | PS | METRONIDAZOLE. | METRONIDAZOLE | 1 | 18900 | ||||||||||||
125487601 | 12548760 | 2 | SS | Atorvastatin | ATORVASTATIN | 1 | 0 | ||||||||||||
125487601 | 12548760 | 3 | SS | EZETIMIBE. | EZETIMIBE | 1 | Oral | 0 | |||||||||||
125487601 | 12548760 | 4 | SS | Insulin | INSULIN NOS | 1 | 0 | ||||||||||||
125487601 | 12548760 | 5 | SS | Clexane | ENOXAPARIN SODIUM | 1 | 0 | ||||||||||||
125487601 | 12548760 | 6 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | |||||||||||
125487601 | 12548760 | 7 | SS | RAMIPRIL. | RAMIPRIL | 1 | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125487601 | 12548760 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125487601 | 12548760 | Acute kidney injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |